TUBERCULOSIS
January, 2005
Diagnosis, Diagnostics,
Immunodiagnosis & Immunodiagnostics:
11142.
Al-Mulhim AS, Al-Ghamdi AM, Al-Marzooq YM, Hashish HM, Mohammad HA, Ali
AM, Gharib IA. The
role of fine needle aspiration cytology and imprint cytology in cervical
lymphadenopathy. Saudi Med J. 2004 Jul;25(7):862-5.
11143.
Angeby KA, Hoffner SE, Diwan VK. Should the 'bleach microscopy method' be
recommended for improved case detection of tuberculosis? Literature review and
key person analysis. Int J Tuberc Lung Dis. 2004 Jul;8(7):806-15. Review.
11144.
Apers L, Wijarajah C, Mutsvangwa J, Chigara N, Mason P, van der Stuyft P.
Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV
prevalence. Int J Tuberc Lung Dis. 2004 Aug;8(8):945-51.
11145.
Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to
gold. Am J Respir Crit Care Med. 2004 Jul 1;170(1):5-6.
11146.
Baumgartner BJ, Eusterman VD, Willard CC, Morris JT. Pathology quiz case
1. Diagnosis: Mycobacterium tuberculosis cervical lymphadenitis (scrofula) with
left parotid gland. Arch Otolaryngol Head Neck Surg. 2004 Aug;130(8):990; diag
992-3.
11147.
Biswas
G, Padhy PK, Parija BL, Sarangi J. Clinico-radiological evaluation of lower lung
field tuberculosis. Antiseptic, Madurai 2003; 100(6):209-11.
11148.
Brassard P, Bruneau J, Schwartzman K, Senecal M, Menzies D. Yield of
tuberculin screening among injection drug users. Int J Tuberc Lung Dis. 2004
Aug;8(8):988-93.
11149.
Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of
tuberculin skin test and new specific blood test in tuberculosis contacts. Am J
Respir Crit Care Med. 2004 Jul 1;170(1):65-9.
11150.
Bukhary ZA, Alrajhi AA. Extrapulmonary tuberculosis, clinical
presentation and outcome. Saudi Med J. 2004 Jul;25(7):881-5.
11151.
Butt T, Ahmad RN, Kazmi SY, Mahmood A. Rapid diagnosis of pulmonary
tuberculosis by mycobacteriophage assay. Int J Tuberc Lung Dis. 2004
Jul;8(7):899-902.
11152.
Coker RJ, Bell A, Pitman R, Hayward A, Watson J. Screening programmes for
tuberculosis in new entrants across Europe. Int J Tuberc Lung Dis. 2004
Aug;8(8):1022-6.
11153.
Delgado JC, Quinones-Berrocal J, Thim S, Miranda LF, Goldfeld AE.
Diagnostic and clinical implications of response to tuberculin in two ethnically
distinct populations from Peru and Cambodia. Int J Tuberc Lung Dis. 2004
Aug;8(8):982-7.
11154.
Garg RK. Diagnostic criteria for neurocysticercosis: some modifications
are needed for Indian patients. Neurology India. 2004 Jun; 52(2): 171-177.
11155.
Gopi PG, Subramani R, Selvakumar N, Santha T, Eusuff SI, Narayanan PR.
Smear examination of two specimens for diagnosis of pulmonary tuberculosis in
Tiruvallur District, south India. Int J Tuberc Lung Dis. 2004 Jul;8(7):824-8.
11156.
Hsu CY, Lu HC, Shih TT. Tuberculous infection of the wrist: MRI features.
AJR Am J Roentgenol. 2004 Sep;183(3):623-8.
11157.
Jenkinson F, Murphy MJ. Pleural effusions: the role of biochemical
analysis. Hosp Med. 2004 Aug;65(8):481-4. Review.
11158.
Kashyap RS, Kainthia RP, Satpute RM, Chandak NH, Purohit HJ, Taori GM,
Daginawala HF. Demonstration of IgG antibodies to 30 Kd protein antigen in CSF
for diagnosis of TBM by antibody capturing ELISA. Neurol India 2004
Sep;52(3):359-62.
11159.
Kumar
GGR, Nigam P. Diagnostic aids in Tuberculosis. Antiseptic, Madurai 2003; 100(6):
219-20.
11160.
Lanka P, Lanka LR, Krishnaswamy B. Role of fine needle aspiration
cytology of lymph nodes in the diagnosis of cutaneous tuberculosis. Indian
Journal of Tuberculosis. 2004 Jul; 51(3): 131-135
11161.
Lin WJ, Lu JJ, Chu CC, Chang TY, Wang CC. Calmette-Guerin bacillus
sternal osteomyelitis diagnosed by DNA sequencing analysis of PNC A. Pediatr
Infect Dis J. 2004 Aug;23(8):784-6.
11162.
Lolge S, Chawla A, Shah J, Patkar D, Seth M. MRI of spinal intradural
arachnoid cyst formation following tuberculous meningitis. Br J Radiol. 2004
Aug;77(920):681-4.
11163.
Mishra
S, Mohapatra S, Panda C. Immunology, immunoptophylaxis and Immunodiagnosis of
tuberculosis. Antiseptic, Madurai 2003; 100(6): 215-18.
11164.
Mizrak B, Aydin NE, Hazneci E, Yakinci C. Immunohistochemistry of
tuberculin skin test. J Trop Pediatr. 2004 Aug;50(4):248-9.
11165.
Prasad
R, Saini JK, Gupta R, Kannaujia RK, Sarin S, Suryakant, Kulshreshth R, Nag VL,
Tripathi AK. A comparative study of clinico-radiological spectrum of
tuberculosis among HIV seropositive and HIV seronegative patients. Indian J
Chest Dis all Sci 2004;46(2):99-103.
11166.
Saito M, Bautista CT, Gilman RH, Bowering A, Levy MZ, Evans CA. The value
of counting BCG scars for interpretation of tuberculin skin tests in a
tuberculosis hyperendemic shantytown, Peru. Int J Tuberc Lung Dis. 2004
Jul;8(7):842-7.
11167.
Samal
KK, Padhy BN, Patnaik B, Mohanty SC. Observation of abacillary pulmonary
tuberculosis in systemic diseases. Antiseptic, Madurai 2003; 100(6): 212-4.
11168.
Scarpellini P, Tasca S, Galli L, Beretta A, Lazzarin A, Fortis C.
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of
Mycobacterium tuberculosis infection. J Clin Microbiol. 2004 Aug;42(8):3469-74.
11169.
Shanmugam M. Subretinal fluid analysis in the diagnosis of choroidal
tuberculosis. Retina. 2004 Aug;24(4):659; author reply 659.
11170.
Shende N, Gupta S, Kumar S, Harinath BC. Levels of antibody, free antigen
and immune complexed antigen by ELISA in different grades of sputum positive
patients of pulmonary tuberculosis. Indian
J of Pathology and Microbiology
July 2004; 47(3): 438-440.
11171.
Singh
V, Raj Kumar. Post TBM hydrocephalus with deceptive CSF profile in a premature:
it is congenital tuberculosis? Neurosci Today 2004;8(2):88-91.
11172.
Swaminathan S, Paramasivan CN, Kumar SR, Mohan V, Venkatesan P.
Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful
tool. Int J Tuberc Lung Dis. 2004 Jul;8(7):896-8.
11173.
Talbot EA, Hay Burgess DC, Hone NM, Iademarco MF, Mwasekaga MJ, Moffat HJ,
Moeti TL, Mwansa RA, Letsatsi P, Gokhale NT, Kenyon TA, Wells CD. Tuberculosis
serodiagnosis in a predominantly HIV-infected population of hospitalized
patients with cough, Botswana, 2002. Clin Infect Dis. 2004 Jul 1;39(1):e1-7.
11174.
Yossepowitch
O, Dan M. Can it be TB? Isr Med Assoc J. 2004 Jul;6(7):427-9. Review.
Pathogenesis:
11175.
Ali S, Almoudaris M. BCG lymphadenitis. Arch Dis Child. 2004
Sep;89(9):812.
11176.
Ayele WY, Neill SD, Zinsstag J, Weiss MG, Pavlik I. Bovine tuberculosis:
an old disease but a new threat to Africa. Int J Tuberc Lung Dis. 2004
Aug;8(8):924-37. Review.
11177.
Caccamo N, Meraviglia S, La Mendola C, Bosze S, Hudecz F, Ivanyi J, Dieli
F, Salerno A. Characterization
of HLA-DR- and TCR-binding residues of an immunodominant and genetically
permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis. Eur J
Immunol. 2004 Aug;34(8):2220-9.
11178.
Donoghue HD, Spigelman M, Greenblatt CL, Lev-Maor G, Bar-Gal GK, Matheson
C, Vernon K, Nerlich AG, Zink AR. Tuberculosis: from prehistory to Robert Koch,
as revealed by ancient DNA. Lancet Infect Dis. 2004 Sep;4(9):584-92.
11179.
Hanscheid T, Monteiro C, Marques-Lito L, Melo-Cristino J, Salgado MJ.
Usefulness of Myco/F Lytic blood cultures (Bactec 9050) in the detection of
Mycobacterium tuberculosis bacteraemia in HIV-infected patients in Portugal. Int
J Infect Dis. 2004 Jul;8(4):253-4.
11180.
Lemus D, Martin A, Montoro E, Portaels F, Palomino JC. Rapid alternative
methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J
Antimicrob Chemother. 2004 Jul;54(1):130-3.
11181.
McNabb A, Eisler D, Adie K, Amos M, Rodrigues M, Stephens G, Black WA,
Isaac-Renton J. Assessment
of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for
routine identification of Mycobacterium species isolated from clinical sources.
J Clin Microbiol. 2004 Jul;42(7):3000-11.
Therapy:
11182.
Burgner D, Scholvinck E, Coren M, Walters S. Chalk and cheese:
symptomatic hypocalcaemia during paediatric anti-tuberculous therapy. J Infect.
2004 Aug;49(2):169-71.
11183.
Goldrick BA. Once dismissed, still rampant: tuberculosis, the second
deadliest infectious disease worldwide. Am J Nurs. 2004 Sep;104(9):68-70.
11184.
Mark Doherty T. New vaccines against tuberculosis. Trop Med Int Health.
2004 Jul;9(7):818-26. Review.
11185.
Pletschette M, Nair S. Editorial: Tuberculosis research: an end to
neglect and negligence. Trop Med Int Health. 2004 Jul;9(7):817.
11186.
van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH,
Springer P, Hoepelman AI, Geelen SP, Kimpen JL, Schoeman JF. Vascular
endothelial growth factor and blood-brain barrier disruption in tuberculous
meningitis. Pediatr Infect Dis J. 2004 Jul;23(7):608-13.
April, 2005
Some Selected Abstracts: | |
1. |
Kabra SK, Lodha R, Seth V. Some current concepts on childhood tuberculosis. Indian J Med Res. 2004 Oct; 120(4):387-97. Review. Department
of Pediatrics, All India Institute of Medical Sciences, D II/23, An sari
Nagger, New Delhi 110-029, India. skkabra@hotmail.com As
children acquire infection with Mycobacterium tuberculosis from adults in
their environment, the epidemiology of childhood tuberculosis (TB) follows
that in adults. While global burden of childhood tuberculosis is unclear,
in developing countries the annual risk of tuberculosis infection in
children is 2- 5 per cent. Nearly 8-20 per cent of the deaths caused by
tuberculosis occur in children. It has been
suggested that BCG vaccination is responsible for decrease in the
occurrence of disseminated and severe disease. Localized forms of illness,
e.g., intrathoracic lymphadenopathy, and localized CNS disease have been
reported to occur with greater frequency in vaccinated children. Human
immunodeficiency virus (HIV) infected children are at an increased risk of
tuberculosis, particularly disseminated disease. Diagnosis of TB in
children presents special problems as the sputum is generally not
available for examination. Diagnostic algorithms include scoring system
utilizing clinical parameters and results of investigations. Various
diagnostic techniques such as improved culture techniques, serodiagnosis,
and nucleic acid amplification have been developed and evaluated to
improve diagnosis of childhood tuberculosis. Serodiagnosis is an
attractive investigation but till date none of the tests showed desirable
sensitivity and specificity. Tests based on nucleic acid amplification are
a promising development. Relatively less experience in children, need for
technical expertise and high cost are the limiting factors for their use
in childhood tuberculosis. Short-course chemotherapy for childhood
tuberculosis is well established. Treatment with intermittent regimens is
comparable to daily regimens. Directly observed treatment strategy (DOTS)
has also shown encouraging results. Pattern of drug resistance among
children with TB tends to reflect those found among adults in the same
population. The rates of drug resistance to any drug vary from 20 to 80
per cent in different geographic regions. |
2. |
Misra
UK, Kalita J. The role of sensory and motor evoked potentials in the
prognosis of Pott's paraplegia. Clin Neurophysiol. 2004 Oct;
115(10):2267-73. Department
of Neurology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences,
Raebareily Road, Lucknow-26014, India. ukmisra@sgpgi.ac.in OBJECTIVE: In view of paucity of evoked potential changes in Pott's paraplegia, it is proposed to evaluate the role of motor and somatosensory evoked potentials in predicting the outcome. METHODS: Consecutive patients with Pott's paraplegia during 1993-2003 were subjected to detailed clinical, radiological and evoked potential study. The latter comprised of tibial somatosensory evoked potential (SEP) and motor evoked potential (MEP) study to tibialis anterior. The patients were clinically evaluated at 6 and 12 months and the outcome was defined into poor (bed ridden), partial (dependent for activities of daily living) and complete recovery (independent). The evoked potential findings were correlated with clinical and radiological findings and outcome. RESULTS: There were 39 patients whose age ranged between 16 and 70 (mean 42.1) years and 22 were females. The mean duration of symptoms was 8.2 months. Sensory motor deficit was present in 18 and pure motor signs in 21 patients. Five patients had quadriplegia and remaining had paraplegia. The muscle weakness was severe in 12 and moderate in 15 patients. In 12 patients, lower limb power was normal but they had lower limb hyper-reflexia with or without spasticity suggesting pyramidal dysfunction. Pinprick and joint position sensations were abnormal in 18 patients. MRI was abnormal in all and revealed cervical involvement in 7, thoracic in 22 and lumbar in 10 patients. Paravertebral soft tissue shadow was present in 36 and cord compression in 30 patients. Motor evoked potential was abnormal in 19 patients (unrecordable in 11 patients, 21 sides and prolonged in 8 patients, 14 sides). SEP was abnormal in 18 patients (unrecordable in 15 patients, 25 sides and prolonged central conduction in 8 patients, 9 sides). Both MEP and SEP were abnormal in 16, normal in 18, and only MEP was abnormal in 3 and only SEP in 2 patients. At 6 month 25 patients had complete, 9 partial and 5 poor recovery. At 1 year 33 had complete and 4 partial recovery. SEP and MEP abnormalities correlated with respective sensory and motor functions, vertebral level and outcome at 6 and 12 months. CONCLUSIONS: MEP and SEP both are helpful in predicting 6-month outcome. Combining SEP and MEP gives stronger correlation with 6-month outcome compared to only MEP or SEP. The potential role of evoked potentials in deciding different therapeutic strategies needs further studies. |
3. |
Gupta S, Shende N, Kumar S, Harinath BC. Isolation of excretory secretory protein 6 kDa antigen (ES-6) and its seroreactivity in patients with different stages of pulmonary tuberculosis and healthy household contacts. Biomedical Research, 2005; 16(1): 23-27. An Excretory Secretory protein antigen of 6 kDa (ES-6) was
isolated from Mycobacterium tuberculosis H37Ra culture
filtrate by gel filtration using fast protein liquid chromatography.
Seroreactivity of ES-6 antigen was compared with earlier reported
diagnostically useful ES-31 and ES-43 antigens at different stage of
pulmonary tuberculosis and in household contacts of the patients. The
ES-31 and ES-43 antigens showed good immune response in chronic and
relapse cases respectively while ES-6 antigen has shown comparatively low
immune response in these cases. However ES-6 showed increased
seroreactivity in household contacts of pulmonary tuberculosis patients.
These results suggest the heterogeneous responses of antigens in different
disease conditions and immune response to
ES-6 antigen may be associated with latent infection for predicting
active disease in course of time, as observed in the follow up of these
individuals. |
Diagnosis, Diagnostics,
Immunodiagnosis & Immunodiagnostics: |
11754.
Chou
YH, Tiu CM, Liu CY, Hong TM, Lin CZ, Chiou HJ, Chiou SY, Chang CY, Chen
MS. Tuberculosis of the parotid gland: sonographic manifestations and
sonographically guided aspiration. J Ultrasound Med. 2004
Oct;23(10):1275-81. 11755.
David
S T, Mukundan U, Brahmadathan k N, Jacob John T. Detecting
mycobacteraemia for diagnosing tuberculosis. Indian J med Res 2004, 119
(6), 259-66. 11756.
D'Souza DTB, Birdi TJ, Dholakia Y, Hira S, Anita NH. Importance
of blood samples for drug diagnosis and drug sensitivity testing in HIV
positive patients with suspected tuberculosis. Indian
Journal of Tuberculosis. 2004 Apr; 51(2): 77-81. 11757.
Gupta
S, Shende N, Kumar S, Harinath BC. Isolation of excretory secretory
protein 6 kDa antigen (ES-6) and its seroreactivity in patients with
different stages of pulmonary tuberculosis and healthy household
contacts. Biomedical Research, 2005; 16(1): 23-27. 11758.
Iwamoto
Y, Miyazawa T, Kurimoto N, Miyazu Y, Ishida A, Matsuo K, Watanabe Y.
Interventional bronchoscopy in the management of airway stenosis
due to tracheobronchial tuberculosis. Chest. 2004 Oct;126(4):1344-52. 11759.
Kabra
SK, Lodha R, Seth V. Some current concepts on childhood tuberculosis.
Indian J Med Res. 2004 Oct;120(4):387-97. Review. 11760.
Kashyap RS, Kainthla RP, Satpute RM, Chandak NH, Purohit HJ,
Taori GM, Daginawala H.F. Demonstration of IgG antibodies to 30 Kd
protein antigen in CSF for diagnosis of tuberculous meningitis by
antibody capturing ELISA. Neurology India. 2004 Sep; 52(3): 359-362 11761.
Kulkarni SB, Vora IM, Abraham S, Srivastava S, Sheth J,
Chaturvedi R. Role of synovial fluid analysis and synovial biopsy in
joint diseases. Bombay Hospital Journal. 2004 Oct; 46(4): 386-390.
11762.
Misra
UK, Kalita J. The role of sensory and motor evoked potentials in the
prognosis of Pott's paraplegia. Clin Neurophysiol. 2004
Oct;115(10):2267-73. 11763.
Ormerod
LP. Tuberculosis and anti-TNF-alpha treatment. Thorax. 2004
Nov;59(11):921. 11764.
Paul
Y. Controversies in BCG immunization. Indian J Pediatr. 2004
Nov;71(11):1040; 11765.
Peloquin
C. Use of therapeutic drug monitoring in tuberculosis patients. Chest.
2004 Dec;126(6):1722-4. 11766.
Schachter
EN. Tuberculosis: a global problem at our doorstep. Chest. 2004
Dec;126(6):1724-5. 11767.
Shenai
S, Rodrigues C, Mehta AP. Newer rapid diagnostic methods for
tuberculosis: a preliminary experience.
Indian
Journal of Tuberculosis. 2004 Oct; 51(4): 219-230. 11768.
Tripathi
DG, Sriram N, Naik VK, Smita P, Seema G, Desai MW. Efficacy of
immunochromatographic techniques for the serodiagnosis of tuberculosis
[letter] Indian Journal of Medical Microbiology. 2004 Apr; 22(2):
131-132. 11769.
Tsai
MH, Huang YC, Lin TY. Development of tuberculoma during therapy
presenting as hemianopsia. Pediatr Neurol. 2004 Nov;31(5):360-3. Review.
11770.
Vernon
AA, Iademarco MF. In the treatment of tuberculosis, you get what you pay
for... Am J Respir Crit Care Med. 2004 Nov 15;170(10):1040-2. |
Pathogenesis: |
11771.
Cohen
J. Medicine. New TB drug promises shorter, simpler treatment. Science.
2004 Dec 10;306(5703):1872. 11772.
de
Castro AB. Respiratory protection: preventing exposure to communicable
agents. Am J Nurs. 2004 Dec;104(12):88. 11773.
Donald
PR, Schoeman JF. Tuberculous meningitis. N Engl J Med. 2004 Oct
21;351(17):1719-20. 11774.
Hizel
K, Maral I, Karakus R, Aktas F. The influence of BCG immunisation on
tuberculin reactivity and booster effect in adults in a country with a
high prevalence of tuberculosis. Clin Microbiol Infect. 2004
Nov;10(11):980-3. 11775.
Jindani
A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for
treatment of newly diagnosed pulmonary tuberculosis: international
multicentre randomised trial. Lancet. 2004 Oct 2;364(9441):1244-51. 11776.
Ojcius
D. AIDS and tuberculosis - a lethal combination. Nat Rev Microbiol. 2004
Nov;2(11):858. 11777.
Quagliarello
V. Adjunctive steroids for tuberculous meningitis--more evidence, more
questions. N Engl J Med. 2004 Oct 21;351(17):1792-4. |
Therapy: |
11778. Nelson R. WHO's tuberculosis control strategy said to be insufficient. Lancet Infect Dis. 2004 Nov;4(11):653. |
July, 2005
Some Selected Abstracts: | |
1. |
1.
Bhatia AS, Gupta S, Shende N, Kumar S.Harinath BC.Serodiagnosis of
childhood tuberculosis by ELISA. Indian J Pediat 2005 May, 72, 383-87. JB Tropical Disease Research Centre & Dept. of
Biochemistry, MGIMS, Sevagram - 442102, Wardha, MS. India. Objective: Diagnosis of childhood tuberculosis remains an enigma despite
the many recent technological developments.
The present study has been taken up with the aim to assess the
diagnostic potential of mycobacterium tuberculosis excretory-secretory
ES-31 antigen and affinity purified anti ES-31 antibodies in the
serodiagnosis of different spectrum of childhood tuberculosis. Methods:
Mycobacterium tuberculosis H37Ra excretory-secretory antigen
(ES-31) and affinity purified goat anti ES-31 antibodies were used in
stick penicillinase ELISA for IgG antibody detection and stick Sandwich
penicillinase ELISA for detection of circulating free and immune complexed
antigen in the sera of 230 children.
Results: Analysis of
tubercular antibody, circulating free and immune complexed antigen (CIC-Ag)
was done in both pulmonary and extrapulmonary form of childhood
tuberculosis and overall sensitivity of 81.4% with a specificity of 93%
was achieved for detection of antitubercular IgG antibodies.
Of the five cases of pulmonary tuberculosis showing absence of IgG
antibody, 3 showed the presence of CIC-Ag and one was found positive for
both free and CIC-Ag. Similarly
out of 8 cases of extrapulmonary childhood tuberculosis missed by IgG
detection 5 were found to be positive for CIC-Ag and 1 showed the positive
reaction for both free and immune complexed antigens.
Conclusion: IgG
antibody to excretory-secretory antigen ES-31 is found to be having good
specificity with acceptable sensitivity in detecting different forms of
childhood tuberculosis. Further detection of circulating free and / or
immunecomplexed antigen can be used as an adjunct tool in the diagnosis of
childhood tuberculosis. |
2. |
Gupta
S, Shende N, Kumar S, Harinath BC. Detection of antibodies to a cocktail of mycobacterial
excretory�secretory antigens in tuberculosis by ELISA and immunoblotting.
Current Science,
2005 June 10;88(11):1825-1827.
JB Tropical Disease Research Centre & Dept. of Biochemistry,
MGIMS, Sevagram - 442102, Wardha, MS. India. The seroreactivity of a cocktail of purified mycobacterial
excretory�secretory (ES) antigens ES-31, ES-41 and ES-43 was assessed by
ELISA and immunoblotting in patients with pulmonary tuberculosis. The
ES-31 antigen was isolated by affinity chromatography and ES-41 and ES-43
were isolated by fast protein liquid chromatography from Mycobacterium
tuberculosis H37Ra culture filtrate. Seven of 27 pulmonary
tuberculosis sera were not reactive to ES-31 antigen by ELISA. However, 6
out of 7 turned positive, when a cocktail of ES-31, ES-41 and ES-43
antigens was used in ELISA. Seroreactivity pattern of cocktail antigen was
studied in immunoblotting using tuberculous sera. Addition of ES-41 and
ES-43 antigens helped in increasing the sensitivity compared to ES- 31
alone. Further, ELISA was observed to be more sensitive than
immunoblotting using a cocktail of antigens. |
3. |
Perez-Guzman
C, Vargas MH, Quinonez F, Bazavilvazo N, Aguilar A. A
cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary
tuberculosis. Chest.
2005 Feb;127(2):643-51. Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502, CP
14080, Mexico City, Mexico. BACKGROUND: Hypocholesterolemia is common among tuberculous
patients and is associated with mortality in miliary cases. Some in vitro
studies have shown that cholesterol is necessary for the good functioning
of macrophages and lymphocytes. STUDY OBJECTIVES: To determine whether a
cholesterol-rich diet could accelerate sputum sterilization in patients
with pulmonary tuberculosis. DESIGN: An 8-week follow-up, randomized,
controlled trial carried out from March 2001 to January 2002. SETTING: A
third-level hospital for respiratory diseases in Mexico City. PATIENTS AND
INTERVENTIONS: Adult patients with newly diagnosed pulmonary tuberculosis
were hospitalized for 8 weeks and randomly assigned to receive a
cholesterol-rich diet (800 mg/d cholesterol [experimental group]) or a
normal diet (250 mg/d cholesterol [control group]). All patients received
the same four-drug antitubercular regimen (ie, isoniazid, rifampin,
pyrazinamide, and ethambutol). MEASUREMENTS AND RESULTS: Every week, a
quantitative sputum culture and laboratory tests were done and respiratory
symptoms were recorded. Patients in the experimental group (10 patients)
and the control group (11 subjects) were HIV-negative and harbored
Mycobacterium tuberculosis that was fully sensitive to antitubercular
drugs. Sterilization of the sputum culture was achieved faster in the
experimental group, as demonstrated either by the percentage of negative
culture findings in week 2 (80%; control group, 9%; p = 0.0019) or by the
Gehan-Breslow test for Kaplan-Meier curves (p = 0.0037). Likewise, the
bacillary population decreased faster (p = 0.0002) in the experimental
group. Respiratory symptoms improved in both groups, but sputum production
decreased faster in the experimental group (p < 0.05). Laboratory test
results did not differ between the groups. CONCLUSIONS: A cholesterol-rich
diet accelerated the sterilization rate of sputum cultures in pulmonary
tuberculosis patients, suggesting that cholesterol should be used as a
complementary measure in antitubercular treatment. |
Diagnosis, Diagnostics,
Immunodiagnosis & Immunodiagnostics: |
|
Pathogenesis: |
|
Therapy: |
|
October, 2005
Some Selected Abstracts: | |
1. |
Almagro
M, Del Pozo J, Rodriguez-Lozano J, Silva JG, Yebra-Pimentel MT, Fonseca E.
Metastatic
tuberculous abscesses in an immunocompetent patient.
Clin Exp Dermatol. 2005 May;30(3):247-9. Department
of Dermatology, Hospital Juan Canalejo, A Coruna, Spain. The
decreased incidence of infectious diseases in developed countries may make
their diagnosis difficult. Cutaneous tuberculosis is an example of this
fact. A 44-year-old man presented with two painful abscesses on his lower
extremities, which developed into chronic ulcers. A cutaneous biopsy
revealed necrotizing granulomas in the dermis. Ziehl-Neelsen and periodic
acid-Schiff stain were negative. Mantoux test was positive. Tc-99m
scintigraphy showed increased uptake in the bone tissue of the left ankle
and right tibiae, without direct relation to cutaneous lesions. Chest
X-ray showed micronodular, apical, bilateral infiltrates, reduced volume
of the right lung, and cavitation of the right superior lobe.
Mycobacterium tuberculosis was grown from sputum and skin biopsy samples.
Isoniazid, rifampin and pyrazinamide treatment for 2 months, followed by
isoniazid and rifampin for 12 months, resulted in complete resolution. The
clinical features of cutaneous tuberculosis in our patient were
characteristic of tuberculous abscesses. Some uncommon findings, such as
the low number of lesions, negative acid-fast resistant stains in
cutaneous biopsy samples and his preserved general state of health, may be
explained by a higher competence of the immune system than is usual in
this clinical subset of disseminated tuberculosis. Cutaneous tuberculosis
should be included in the differential diagnosis of cutaneous abscesses in
immunocompetent patients. |
2. |
Donald
PR, Schaaf HS, Schoeman JF Tuberculous meningitis and miliary tuberculosis: the
Rich focus revisited.
J Infect. 2005 Apr;50(3):193-5. The
Department of Paediatrics and Child Health, Tygerberg Children's Hospital
and The Faculty of Health Sciences, The University of Stellenbosch, P.O.
Box 19063, 7505 Tygerberg, South Africa. prd@sun.ac.za Tuberculous
meningitis (TBM) develops most often when a caseating meningeal or
sub-cortical focus, the Rich focus, discharges its contents into the
subarachnoid space. It is recognized that TBM is frequently accompanied by
miliary tuberculosis, but the relationship between the development of the
Rich focus and miliary tuberculosis remains controversial. The original
descriptions of Arnold Rich and Howard McCordock are reviewed together
with the work of other pathologists and the observations of the natural
history of tuberculosis by astute clinicians such as Arvid Wallgren and
Edith Lincoln. Rich and McCordock dissociated miliary tuberculosis from a
role in the pathogenesis of TBM, and this view continues to appear in
reviews and textbooks dealing with TBM. We suggest, particularly in
childhood, that miliary tuberculosis is indeed directly involved in the
pathogenesis of TBM in as much as that the overwhelming bacillaemia that
accompanies miliary tuberculosis serves to increase the likelihood that a
meningeal or sub-cortical Rich focus will be established, which may in its
turn caseate and give rise to TBM. |
3. |
DeRiemer
K, Garcia-Garcia L, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa
A, Small PM, Sifuentes-Osornio J, Ponce-de-Leon A.Does
DOTS work in populations with drug-resistant tuberculosis?
Lancet. 2005 Apr 2-8;365(9466):1239-45. Division
of Infectious Diseases and Geographic Medicine, Stanford University
Medical Center, Stanford, CA, USA. BACKGROUND: Directly observed therapy (DOTS) is the main strategy for prevention and control of tuberculosis worldwide. However, its effect on tuberculosis transmission in populations with moderate rates of drug-resistant disease is not known. METHODS: This population-based prospective study in southern Mexico between March, 1995, and February, 2000, was based on passive case finding and detection of acid-fast bacilli in sputum samples to diagnose pulmonary tuberculosis. We also used cultures, drug-susceptibility testing, bacterial genotyping, and monitoring of treatment outcomes. FINDINGS: We enrolled 436 patients; the HIV seroprevalence rate was 2%. We used three indicators to monitor continuing tuberculosis transmission: the incidence rate of pulmonary tuberculosis, which decreased by 54.4% between 1995 and 2000, from 42.1 to 19.2 per 10(5) population (p=0.00048); the percentage of clustered pulmonary tuberculosis cases, which decreased by 62.6% from 22% to 8% (p=0.02); and the rate of primary drug resistance, which decreased by 84.0% from 9.4 to 1.5 per 10(5) population (p=0.004). Rates of multidrug-resistant (MDR) tuberculosis also decreased (p<0.0001). The case-fatality ratio was 12% for MDR tuberculosis (five of 41), 7% for strains resistant to at least one drug after exclusion of MDR (four of 55), and 3% for pansusceptible strains (nine of 272). There were 13 treatment failures (11%) in 1995 and one (2%) in 2000 (p=0.012). INTERPRETATION: Even in settings with moderate rates of MDR tuberculosis, DOTS can rapidly reduce the transmission and incidence of both drug-susceptible and drug-resistant tuberculosis. However, further interventions, such as drug-susceptibility testing and standardised or individualised treatment regimens, are needed to reduce mortality rates for MDR tuberculosis. |
4. |
Geng
E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic
correlates of primary and reactivation tuberculosis: a molecular
epidemiology study. JAMA. 2005 Jun 8;293(22):2740-5. College
of Physicians and Surgeons, Columbia University, New York, NY, USA. CONTEXT:
The traditional teaching that pulmonary tuberculosis characterized by
lymphadenopathy, effusions, and lower or mid lung zone infiltrates on
chest radiography represents "primary" disease from recently
acquired infection, whereas upper lobe infiltrates and cavities represent
secondary or reactivation disease acquired in the more distant past, is
not based on well-established clinical evidence. Furthermore, it is not
known whether the atypical radiograph common in human immunodeficiency
virus (HIV)-associated tuberculosis is due to a preponderance of primary
progressive disease or altered immunity. OBJECTIVE: To analyze the
relationship between recently acquired and remotely acquired pulmonary
tuberculosis, clinical and demographic variables, and radiographic
features by using molecular fingerprinting and conventional epidemiology.
DESIGN, SETTING, AND POPULATION: A retrospective, hospital-based series of
456 patients treated at a New York City medical center between 1990 and
1999. Eligible patients had to have had at least 1 positive respiratory
culture for Mycobacterium tuberculosis and available radiographic data.
MAIN OUTCOME MEASURES: Radiographic appearance as measured by the presence
or absence of 6 features: upper lobe infiltrate, cavitary lesion,
adenopathy, effusions, lower or mid lung zone infiltrate, and miliary
pattern. Radiographs were considered typical if they had an upper lobe
infiltrate or cavity whether or not other features were present. Atypical
radiographs were those that had adenopathy, effusion, or mid lower lung
zone infiltrates or had none of the above features. RESULTS: Human
immunodeficiency virus infection was most commonly associated with an
atypical radiographic appearance on chest radiograph with an odds ratio of
0.20 (95% confidence interval, 0.13-0.31). Although a clustered
fingerprint, representing recently acquired disease, was associated with
typical radiograph in univariate analysis (odds ratio, 0.68; 95%
confidence interval, 0.47-0.99), the association was lost when adjusted
for HIV status. CONCLUSIONS: Time from acquisition of infection to
development of clinical disease does not reliably predict the radiographic
appearance of tuberculosis. Human immunodeficiency virus status, a
probable surrogate for the integrity of the host immune response, is the
only independent predictor of radiographic appearance. The altered
radiographic appearance of pulmonary tuberculosis in HIV is due to altered
immunity rather than recent acquisition of infection and progression to
active disease. |
5. |
Immanuel
C, Victor L, Chelvi KS, Padmapriyadarsini C, Rehman F, Iliayas S,
Swaminathan S. Serum neopterin levels in HIV infected patients with &
without tuberculosis. Indian J Med Res. 2005 Apr;121(4):220-5. Tuberculosis
Research Centre (ICMR), Mayor V.R. Ramanthan Road, Chetput, Chennai,
India. BACKGROUND
& OBJECTIVE: Three categories of prognostic markers are best
documented as having significance in relation to prognosis of HIV
infection. These include HIV viral load, CD4 T-cell levels and plasma
levels of soluble markers of immune activation. The plasma activation
markers, like neopterin, tumor necrosis factor alpha (TNF-alpha),
interleukins etc., are products of cytokine activity and represent
immunologic changes throughout the body. There is not much information
available on serum neopterin estimation in patients infected with both HIV
and tuberculosis (TB), though neopterin levels are known to be elevated in
pulmonary TB patients. In this study we attempted to correlate neopterin
levels with the presence of tuberculosis in HIV infected and uninfected
individuals and studied the changes after antituberculosis treatment.
METHODS: Serum neopterin concentrations were measured by high performance
liquid chromatography (HPLC) in 25 HIV-seropositive (HIV-TB) and
10-seronegative (TB) patients with tuberculosis before, during and at the
end of antituberculosis therapy (ATT). S-neo was also measured in 10 HIV-seropositive
asymptomatic individuals and 10 healthy controls. The results were
correlated with clinical, bacteriological and immunological status.
RESULTS: All TB patients regardless of HIV status had elevated s-neo
concentrations at diagnosis, which declined gradually during treatment.
Patients with HIV/TB with CD4 counts < 200/mm(3) had the highest levels
at baseline with a steep fall during treatment. The median level at the
end of treatment was significantly higher in HIV/TB than in TB patients,
despite clinical improvement and bacteriological clearance of
Mycobacterium tuberculosis. HIV infected asymptomatic individuals had
neopterin levels that were higher than healthy controls but lower than
HIV-TB patients. INTERPRETATION & CONCLUSION: Serum neopterin levels
are elevated in HIV-positive patients, with the highest levels in those
with tuberculosis and CD4 counts < 200/mm(3). Though the levels
decrease with anti tuberculosis therapy, persistently elevated levels
indicate progressive HIV disease and a poor prognosis. |
6. |
Pai
M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley
CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr Mycobacterium
tuberculosis infection in health care workers in rural India: comparison
of a whole-blood interferon gamma assay with tuberculin skin testing.
JAMA. 2005 Jun 8;293(22):2746-55. Department
of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram,
India. madhupai@berkeley.edu CONTEXT:
Mycobacterium tuberculosis infection in health care workers has not been
adequately studied in developing countries using newer diagnostic tests.
OBJECTIVES: To estimate latent tuberculosis infection prevalence in health
care workers using the tuberculin skin test (TST) and a whole-blood
interferon gamma (IFN-gamma) assay; to determine agreement between the
tests; and to compare their correlation with risk factors. DESIGN,
SETTING, AND PARTICIPANTS: A cross-sectional comparison study of 726
health care workers aged 18 to 61 years (median age, 22 years) with no
history of active tuberculosis conducted from January to May 2004, at a
rural medical school in India. A total of 493 (68%) of the health care
workers had direct contact with patients with tuberculosis and 514 (71%)
had BCG vaccine scars. INTERVENTIONS: Tuberculin skin testing was
performed using 1-TU dose of purified protein derivative RT23, and the IFN-gamma
assay was performed by measuring IFN-gamma response to early secreted
antigenic target 6, culture filtrate protein 10, and a portion of
tuberculosis antigen TB7.7. MAIN OUTCOME MEASURES: Agreement between TST
and the IFN-gamma assay, and comparison of the tests with respect to their
association with risk factors. RESULTS: A large proportion of the health
care workers were latently infected; 360 (50%) were positive by either TST
or IFN-gamma assay, and 226 (31%) were positive by both tests. The
prevalence estimates of TST and IFN-gamma assay positivity were comparable
(41%; 95% confidence interval [CI], 38%-45% and 40%; 95% CI, 37%-43%,
respectively). Agreement between the tests was high (81.4%; kappa = 0.61;
95% CI, 0.56-0.67). Increasing age and years in the health profession were
significant risk factors for both IFN-gamma assay and TST positivity. BCG
vaccination had little impact on TST and IFN-gamma assay results.
CONCLUSIONS: Our study showed high latent tuberculosis infection
prevalence in Indian health care workers, high agreement between TST and
IFN-gamma assay, and similar association between positive test results and
risk factors. Although TST and IFN-gamma assay appear comparable in this
population, they have different performance and operational
characteristics; therefore, the decision to select one test over the other
will depend on the population, purpose of testing, and resource
availability. |
7. |
Shende
N, Gupta S, Bhatia AS, Kumar S, Harinath BC. Detection of free and immune
complexed serine protease and its antibody in patients of tuberculosis
with and without HIV co-infection. Int J Tuberc Lung Dis. 2005
Aug;9(8):915-9. Jamnalal Bajaj Tropical Disease Research Centre & Department of Biochemistry, MGIMS, Sevagram � 442 102, Wardha, MS, India. jbtdrc_wda@sancharnet.in OBJECTIVE: To understand the usefulness of detecting tu�berculous
IgG antibodies against mycobacterial excretory�-secretory 31 kDa serine
protease antigen (SEVA TB ES-31) and circulating free and circulating
immune-complexed (CIC) serine protease in TB
patients with and without HIV infection. DESIGN: Serum was collected from 144 individuals: pa�tients
with TB, with TB-HIV
co-infection and HIV infec�tion only, and ill and healthy
controls. SEVA TB ES-31 antigen, a serine protease isolated from Mycobacterium
tuberculosis H37Ra culture fluid, was used in
indirect penicillinase ELISA to detect tuberculous antibodies. Similarly,
affinity purified anti-ES-31 antibody was used in
sandwich ELISA to detect circulating free and CIC serine protease, RESULTS: There was less sensitivity for
tuberculous antibody in HIV-infected TB patients (46%) than in those with TB alone (87%) using mycobacterial serine
protease. However, the sensitivity of detection of TB in the presence of
HIV increased to 87% by concomitant detec�tion of circulating free and
CIC serine protease antigen. CONCLUSION: Detection of free and CIC
tuberculous serine protease antigen along with antibody is more use�ful
far detecting TB in the presence of HIV co-infection. |
8. |
Steele
AW, Eisert S, Davidson A, Sandison T, Lyons P, Garrett N, Gabow P, Ortiz
E.Using
computerized clinical decision support for latent tuberculosis infection
screening. Am J
Prev Med. 2005 Apr;28(3):281-4. Information
Services, Denver Health (1932), 660 Bannock Street, Denver, CO 80218, USA.
asteele@dhha.org BACKGROUND:
The Centers for Disease Control and Prevention (CDC) has published
guidelines recommending screening high-risk groups for latent tuberculosis
infection (LTBI). The goal of this study was to determine the impact of
computerized clinical decision support and guided web-based documentation
on screening rates for LTBI. DESIGN: Nonrandomized, prospective,
intervention study. SETTING AND PARTICIPANTS: Participants were 8463
patients seen at two primary care, outpatient, public community health
center clinics in late 2002 and early 2003. INTERVENTION: The CDC's LTBI
guidelines were encoded into a computerized clinical decision support
system that provided an alert recommending further assessment of LTBI risk
if certain guideline criteria were met (birth in a high-risk TB country
and aged <40). A guided web-based documentation tool was provided to
facilitate appropriate adherence to the LTBI screening guideline and to
promote accurate documentation and evaluation. Baseline data were
collected for 15 weeks and study-phase data were collected for 12 weeks.
MAIN OUTCOME MEASURES: Appropriate LTBI screening according to CDC
guidelines based on chart review. RESULTS: Among 4135 patients registering
during the post-intervention phase, 73% had at least one CDC-defined risk
factor, and 610 met the alert criteria (birth in a high-risk TB country
and aged <40 years) for potential screening for LTBI. Adherence with
the LTBI screening guideline improved significantly from 8.9% at baseline
to 25.2% during the study phase (183% increase, p < 0.001).
CONCLUSIONS: This study demonstrated that computerized, clinical decision
support using alerts and guided web-based documentation increased
screening of high-risk patients for LTBI. This type of technology could
lead to an improvement in LTBI screening in the United States and also
holds promise for improved care for other preventive and chronic
conditions. |
Diagnosis, Diagnostics,
Immunodiagnosis & Immunodiagnostics: |
12960. Akgun Y. Intestinal and peritoneal tuberculosis: changing trends over 10 years and a review of 80 patients. Can J Surg. 2005 Apr;48(2):131-6. 12961. Al-Jahdali H, Memish ZA, Menzies D. The utility and
interpretation of tuberculin skin tests in the Middle East. Am J Infect
Control. 2005 Apr;33(3):151-6. 12962. Almagro M, Del Pozo J, Rodriguez-Lozano J, Silva JG, Yebra-Pimentel MT, Fonseca E. Metastatic tuberculous abscesses in an immunocompetent patient. Clin Exp Dermatol. 2005 May;30(3):247-9. 12963. Alyas F, Lewis K, Williams M, Moody AB, Wong KT, Ahuja AT, Howlett DC. Diseases of the submandibular gland as demonstrated using high resolution ultrasound. Br J Radiol. 2005 Apr;78(928):362-9. Review. 12964. Bateman C. Are we losing the TB battle? S Afr Med J. 2005 May;95(5):292-4. 12965. Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005 Jun;26(2):247-71, vi. Review. 12966. Campbell S, Gibson M, Mee A. Image of the month. Gastroenterology. 2005 Apr;128(4):818, 1152. 12967. Chadha VK, Suryanarayana L, Suryanarayan HV, Srikantaramu N, Kumar P. Protective effect of BCG among children vaccinated under universal immunization programme. Indian J Pediat 2004;71(12):1069-74. 12968. Chanet V, Baud O, Deffond D, Romaszko JP, Beytout J. Pseudotumor presentation of intracerebral tuberculomas. South Med J. 2005 Apr;98(4):489-91. 12969. Chen HA, Cheng NC, Lin KP, Liao HT, Chen CH, Huang DF. Mononeuropathy multiplex and chylothorax as earlier manifestations of pulmonary tuberculosis. J Intern Med. 2005 Jun;257(6):561-3. 12970. Dasgupta S, Chandran V, Bhinge A, Sewlikar S, Nimbkar A, Dattad. Role of L-lysine HCI in adoptive immune therapy towards development of suitable tuberculosis vaccination. Indian J Expl Biol 2004; 42(8): 758-65. 12971. Dheda K, Chang JS, Kim LU, Huggett JF, Johnson MA, Zumla A, Rook GA. Interferon gamma assays for tuberculosis. Lancet Infect Dis. 2005 Jun;5(6):324-5; author reply 325-7. 12972. Geng E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA. 2005 Jun 8;293(22):2740-5. 12973. Goyal S, Lim KT, Yap CH, Ryan EW, Mohajeri M. Chronic constrictive pericarditis: is tuberculosis still a cause? Med J Aust. 2005 Apr 4;182(7):353. 12974. Immanuel C, Victor L, Chelvi KS, Padmapriyadarsini C, Rehman F, Iliayas S, Swaminathan S. Serum neopterin levels in HIV infected patients with & without tuberculosis. Indian J Med Res. 2005 Apr;121(4):220-5. 12975. Jai Bikhchandani, Malik VK, Kumar V, Sharma S. Hepatic tuberculosis mimicking carcinoma gall bladder. Indian Journal of Gastroenterology. 2005 Jan-Feb; 24(1): 25. 12976. Jain AK, Sinha S. Evaluation of systems of grading of neurological deficit in tuberculosis of spine. Spinal Cord. 2005 Jun;43(6):375-80. 12977. Jalali U, Rasul S, Khan A, Baig N, Khan A, Akhter R. Tuberculous mastitis. J Coll Physicians Surg Pak. 2005 Apr;15(4):234-7. 12978. Kang ES, Do MY, Park SY, Hur KY, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Hypercalcemia in hepatic tuberculosis: a case report in Korea. Am J Trop Med Hyg. 2005 Apr;72(4):368-9. 12979. Kim DJ, Im JG, Goo JM, Lee HJ, You SY, Song JW. Chronic tuberculous empyema: relationships between preoperative CT findings and postoperative improvement measured by pulmonary function testing. Clin Radiol. 2005 Apr;60(4):503-7. 12980. Moore D, Evans C, Gilman R, Vargas D, Escombe R. Appropriate technology in tuberculosis diagnostics. Lancet. 2005 Apr 30-May 6;365(9470):1541-2. 12981. Negi SS, Kan SFB, Gupta S, Pasha ST, Khare S, Lal S. Comparison of the conventional diagnostic modalities, bactec culture and polymerase chain reaction test for diagnosis of tuberculosis. Indian Journal of Medical Microbiology. 2005 Jan; 23(1): 29-33. 12982. Padmavathy L, Rao LL, Ramanadhan, Shakila. Mycobacterial antigen in tissues in diagnosis of cutaneous tuberculosis. Indian Journal of Tuberculosis. 2005 Jan; 52(1): 31-35. 12983. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005 Jun 8;293(22):2746-55. 12984. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, Higgins DE, Daly MJ, Bloom BR, Kramnik I. Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005 Apr 7;434(7034):767-72. 12985. Raju R, Suneetha S, Sagili K, Vani MC, Saraswathi V, Satyanarayana AVV, Suneetha LM. Diagnostic role of the antibody response to the 38kda, 16kDa proteins and lipoarabinomannan of mycobacterium tuberculosis. Indian Journal of Clinical Biochemistry. 2005 Jan; 20(1): 123-128. 12986. Ringold S, Lynm C, Glass RM. JAMA patient page. Tuberculosis. JAMA. 2005 Jun 8;293(22):2820. 12987. Saroja S, Usha K. Haematological and biochemical parameters during chemotherapy in pulmonary tuberculosis patients. Indian J Nutr Diet 2003;40(6):198-204. 12988. Sharma SK, Mohan A. multidrug-resistant tuberculosis. Indian J Med Res 2004;120(4): 354-76. 12989. Shende N, Gupta S, Bhatia AS, Kumar S, Harinath BC. Detection of
free and immune complexed serine protease and its antibody in patients
of tuberculosis with and without HIV co-infection. Int J Tuberc Lung
Dis. 2005 Aug;9(8):915-9. 12990. Steele AW, Eisert S, Davidson A, Sandison T, Lyons P, Garrett N, Gabow P, Ortiz E.Using computerized clinical decision support for latent tuberculosis infection screening. Am J Prev Med. 2005 Apr;28(3):281-4. 12991. Swaminathan S, Raghavan A, Datta M, Paramasivan CN, Saravanan KC. Computerized tomography detects pulmonary lesions in children with normal radiographs diagnosed to have tuberculosis. Indian Pediatrics. 2005 Mar; 42(3): 258-261. 12992. Tabbara KF. Ocular tuberculosis: anterior segment. Int Ophthalmol Clin. 2005 Spring;45(2):57-69. Review. 12993. Tenpe S, Tankhiwale NS, Fule RP, Powar RM. Study of Candidiasis in immunocompromised patient. Antiseptic. 2005 Feb; 102(2): 83-84. 12994. Tufan K, Dogulu F, Kardes O, Oztanir N, Baykaner MK. Dorsolumbar junction spinal tuberculosis in an infant: case report. J Neurosurg. 2005 May;102(4 Suppl):431-5. 12995. Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev. 2005 Jun;205:229-43. Review. 12996. Wanchu A. Advances in serology for diagnosing TB in the HIV infected. Indian Journal of Chest Diseases and Allied Sciences. 2005 Jan-May; 47(1): 31-37. 12997. Whalen CC. Diagnosis of latent tuberculosis infection: measure for measure. JAMA. 2005 Jun 8;293(22):2785-7. 12998. Winzer KJ, Menenakos C, Braumann C, Mueller JM, Guski H. Breast mass due to pectoral muscle tuberculosis mimicking breast cancer in a male patient. Int J Infect Dis. 2005 May;9(3):176-7. 12999. Zarocostas J. WHO: big gaps remain in global tuberculosis case detection. Lancet Infect Dis. 2005 May;5(5):263. |
Pathogenesis: |
13000. Abal AT, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma PN. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med. 2005 Apr;99(4):415-20. 13001. Bellamy R. Genetic susceptibility to tuberculosis. Clin Chest Med. 2005 Jun;26(2):233-46, vi. Review. 13002. Bellet JS, Prose NS. Skin complications of Bacillus Calmette-Guerin immunization. Curr Opin Infect Dis. 2005 Apr;18(2):97-100. Review. 13003. Donald PR, Schaaf HS, Schoeman JF. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect. 2005 Apr;50(3):193-5. 13004. Falzari K, Zhu Z, Pan D, Liu H, Hongmanee P, Franzblau SG. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005 Apr;49(4):1447-54. |
Therapy: |
13005. Das Gupta A, Mania RN, Sahu GN. Treatment of HIV related tuberculosis: experience from a tertiary care hospital in eastern India. Lung India. 2005 Jan-Mar; 22(1): 5-11. 13006. DeRiemer K, Garcia-Garcia L, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa A, Small PM, Sifuentes-Osornio J, Ponce-de-Leon A. Does DOTS work in populations with drug-resistant tuberculosis? Lancet. 2005 Apr 2-8;365(9466):1239-45. 13007. Hazra A, Laha B. Chemotherapy of osteoarticular. Indian Journal of Pharmacology. 2005 Feb; 37(1): 5-9. 13008. Jain NK, Banerjee S, Agnihotri SP, Koolwaal S, Joshi N, Shubhranshu. Pyrazinamide therapy and severity of haemoptysis. Indian Journal of Tuberculosis. 2005 Apr; 52(2): 79-83. 13009. Nanware SK, Lrothi D; Joshi JM. Tuberculous broncho-esophageal fistula managed conservatively. Lung India. 2005 Apr; 22(2): 65-67. 13010. Pandey R, Khuller GK. Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother. 2005 Apr;55(4):430-5. 13011. Reichman LB. Defusing the global timebomb. J Public Health Policy. 2005 Apr;26(1):115-21. |